Position in NRXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$81,400
New position
Shares Held
11,000
first reported quarter
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestmark Advisory Solutions, Inc. holds $60,281,695 across 32 Biotechnology names. NRXS ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
256,779 | $12,214,977 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
550,144 | $7,052,845 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
367,153 | $5,309,032 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
176,865 | $4,214,692 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,589 | $3,172,712 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,957 | $3,106,577 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
726,986 | $2,231,847 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
6,681 | $2,152,551 |
All Filings in NRXS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $81,400 | 11,000 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||